To identify and characterize a novel MRSA sequence type ST3390 from the CC5 lineage, focusing on its pathogenic capabilities and genomic features, which may have significant implications for MRSA evolution.
Key Findings:
ST3390 strains lack the staphyloxanthin pigment due to a 6aa deletion in the CrtN protein.
High levels of cytotoxicity towards human neutrophils were observed in ST3390 strains compared to other CC5 lineages.
Unique hybrid SCCmec types were identified, with 90% of Tampa strains possessing components of SCCmecIa, SCCmecIIa, and/or SCCmecVIII.
Only 65 recorded instances of ST3390 infections globally, with a significant concentration in Tampa, and unique spa-types were identified, indicating genetic diversity.
Interpretation:
The emergence of ST3390 highlights the evolving pathogenic potential of CC5 MRSA strains, indicating a shift towards more virulent hospital-associated infections, which poses new challenges for public health.
Limitations:
Limited number of recorded ST3390 infections may not represent its true prevalence, potentially underestimating its impact.
Study primarily focused on strains from a single geographic location (Tampa), which may limit the generalizability of the findings.
Conclusion:
This study provides critical insights into the pathogenicity and genomic diversity of the ST3390 MRSA lineage, contributing to the understanding of MRSA evolution and its implications for public health, emphasizing the need for ongoing surveillance.
by Emily A Felton, Mary-Elizabeth Jobson, Nathanial J Torres, Rachel M Washburn, Ariana M Virgillio, Joshua Alvior, Eleonora Cella, Amorce Lima, Deanna Becker, Suzane Silbert, Taj Azarian, Kami Kim, Lindsey N Shaw
